MARIA BETANCUR: Open Payments
NPI 1295507200 · NORCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,789 in 100 payments from 18 companies in 2025. Trend: 2023 $60 · 2024 $1,433 · 2025 $2,789
Food & beverage: $2,711Education: $78
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $617 |
| AbbVie Inc. | 27 | $583 |
| Janssen Biotech, Inc. | 10 | $344 |
| AstraZeneca Pharmaceuticals LP | 6 | $337 |
| GlaxoSmithKline, LLC. | 7 | $204 |
| SOBI, INC | 2 | $114 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Actelion Pharmaceuticals US, Inc. | 4 | $88 |
| Invivyd Inc | 3 | $68 |
| Aurinia Pharma U.S., Inc. | 2 | $56 |
Products named: RINVOQ, TREMFYA, SAPHNELO, KRYSTEXXA, OTEZLA, SKYRIZI, BENLYSTA, Kineret.
Industry payments across GA — which companies pay providers there.
